Related Experiment Video
Updated: Sep 14, 2025

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
ACG Clinical Guideline Update: Ulcerative Colitis in Adults
David T Rubin1, Ashwin N Ananthakrishnan2, Corey A Siegel3
1Inflammatory Bowel Disease Center, University of Chicago Medicine, Chicago, Illinois, USA.
None:
Ulcerative colitis is an idiopathic inflammatory disorder of unknown etiology that seems to be rising in incidence and prevalence throughout the world. These guidelines were developed to indicate the preferred approach to the management of adult patients with ulcerative colitis as established by valid scientific research and represent the official practice recommendations of the American College of Gastroenterology under the auspices of the Practice Parameters Committee. The scientific evidence for the recommendations made in these guidelines was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation process, assessing the quality of the evidence (high, moderate, low, or very low) and assigning a strength of recommendation based on its apparent clinical benefit (strong or conditional). In instances where the available evidence was not appropriate for a formal Grading of Recommendations Assessment, Development, and Evaluation recommendation, but there was consensus of significant clinical merit, statements were developed using expert consensus (termed key concept statements). These guidelines are meant to be broadly applicable to practitioners regardless of specialty or interest and should be viewed as the preferred, but not only, approach to clinical scenarios. As opposed to standards of care, guidelines are inherently flexible, and physicians should use them as tools in choosing the best course in a specific clinical situation. These guidelines represent the state of the evidence at the time of this publication. As new evidence emerges, these guidelines will be continuously reviewed, and updates will be published as needed to assure continued validity.
More Related Videos
08:51Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
Published on: August 24, 2019
05:50Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
Published on: September 22, 2023
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: